| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.1 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.42 | 0.1 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.079 | 0.1 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.071 | 0.1 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |